D.E. Shaw & Co’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102M Buy
603,465
+54,352
+10% +$9.39M 0.08% 373
2025
Q4
$100M Buy
549,113
+252,826
+85% +$35.3M 0.08% 401
2025
Q3
$36M Buy
296,287
+95,523
+48% +$10.8M 0.03% 823
2025
Q2
$21M Sell
200,764
-346,901
-63% -$36.7M 0.02% 1007
2025
Q1
$63.9M Buy
547,665
+527,319
+2,592% +$60.1M 0.08% 402
2024
Q4
$1.72M Buy
20,346
+17,446
+602% +$1.6M ﹤0.01% 2835
2024
Q3
$261K Sell
2,900
-3,434
-54% -$300K ﹤0.01% 4045
2024
Q2
$510K Sell
6,334
-1,435
-18% -$106K ﹤0.01% 3609
2024
Q1
$620K Sell
7,769
-1,415
-15% -$119K ﹤0.01% 3379
2023
Q4
$731K Buy
+9,184
New +$614K ﹤0.01% 3337
2022
Q3
Sell
-6,762
Closed -$259K 5184
2022
Q2
$259K Sell
6,762
-148,630
-96% -$4.7M ﹤0.01% 4421
2022
Q1
$6.43M Buy
+155,392
New +$4.82M 0.01% 2034
2021
Q4
Sell
-13,939
Closed -$513K 5398
2021
Q3
$459K Sell
13,939
-9,110
-40% -$355K ﹤0.01% 4140
2021
Q2
$1.55M Sell
23,049
-10,169
-31% -$610K ﹤0.01% 3179
2021
Q1
$1.88M Sell
33,218
-133,964
-80% -$9.42M ﹤0.01% 2645
2020
Q4
$13.6M Sell
167,182
-64,060
-28% -$4.79M 0.02% 1185
2020
Q3
$16.5M Sell
231,242
-4,461
-2% -$348K 0.02% 944
2020
Q2
$19.4M Sell
235,703
-122,992
-34% -$9.47M 0.03% 795
2020
Q1
$21.1M Buy
358,695
+275,232
+330% +$22.4M 0.04% 593
2019
Q4
$8.63M Sell
83,463
-36,488
-30% -$1.47M 0.01% 1313
2019
Q3
$2.43M Buy
119,951
+85,195
+245% +$2.19M ﹤0.01% 2214
2019
Q2
$895K Buy
+34,756
New +$697K ﹤0.01% 2741

Other funds holding AXSM